Close Menu

Researchers at Cancer Research UK have developed a method to assess HapMap CNV calls, according to an article published this week in PNAS. Looking across the genome, they discuss a class of CNVs that are misclassified and how often it happens. They hope their method can be used at initial stages of CNV classification, to avoid mistakes and give "more robust results."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.